Cancer - breast news and cancer - breast widget

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for cancer and serious viral infections, announced that updated preliminary data from the first stage of its Phase II trial evaluating bavituximab in combination with docetaxel showed that 10 of 14 (71%) evaluable breast cancer patients achieved an objective tumor response according to RECIST criteria.

Three-dimensional (3-D) power Doppler ultrasound helps radiologists distinguish between malignant and benign breast masses, according to a new study being published in the November issue of Radiology. "Using 3-D scans promises greater accuracy due to more consistent sampling over the entire tumor," said lead author, Gerald L. LeCarpentier, Ph.D., assistant professor in the Department of Radiology at University of Michigan in Ann Arbor.

Over half of breast cancers occur in women aged 65 and over and so in a bid to improve treatments and outcomes for women in this age-group, researchers at Nottingham University Hospitals NHS Trust (NUH) have joined a national research trial which will provide fresh hope for millions of women diagnosed with breast cancer. The multi-centre trial will study the effectiveness of surgery versus 'anti-hormone medications as treatment of early breast cancer in women over 75.

Title: 3-D Doppler Ultrasound Helps ID breast CancersCategory: health newscreated: 10/22/2008 2:00:00 amlast Editorial review: 10/22/2008

Title: Interventions to Promote Breastfeeding SucceedCategory: health newscreated: 10/22/2008 2:00:00 amlast Editorial review: 10/22/2008

Title: Are Fat Injections Safe for Breasts?Category: health newscreated: 10/22/2008Last Editorial review: 10/22/2008